| Location | Philadelphia, PA |
| Industry | Medical Devices and Supplies |
| Salary | $172,000–$258,000 Per Year |
| Company Size | 10,000 employees or more |
| Year Founded | 2003 |
| Website | https://www.jazzpharma.com/ |
If you are a current Jazz employee please apply via the Internal Career site.
Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Essential Functions
Support and lead the development and execution of COA strategies and tactical plans across the Oncology and Neuroscience Therapeutic Areas globally, in both the US and EUR/International regions, in collaboration with cross-functional teams (i.e., Global Molecule Teams, brands, Global Value & HEOR, Global Medical Affairs, and other groups).
Support and lead the collaboration with functional leadership and senior leadership to build awareness about the potential role of COAs in product development, commercial development, indication identification, and other activities.
Actively build trust and lines of communication with internal collaborators in both the US and EUR/International regions: Patient Advocacy, Procurement, Finance, Biostats, Clinical, Medical Affairs, HEOR, Commercial, Market Access, Legal, etc.
Work with the Head of PCO and cross-functional teams to identify COA measurement approaches (using existing or de novo measures) and advise COA endpoint strategies
In collaboration with the Head of PCO and other PCO team members, define the scope of work for and manage relationships with vendors and KOLs for the timely completion of COA projects, ensuring quality, consistency, and compliance.
Manage relationships with vendors for the timely completion of COA projects, ensuring quality, consistency, and compliance with tasks including but not limited to:
Supporting and leading RFP/RFQ development and support to procure COA services
Attends all project team meetings to track project timelines and deliverables
Performs project administrative functions
Point of contact for financial communications including invoicing, payment, and accrual discussions
Establishes and maintains storage of study documents
PV Project Lead/Adverse Event Monitor
Coordinates and secures all internal Jazz approvals, yielding study materials ready for ethics submission
Secures FMV approval for any HCP or patient engagement
Support with forecasts and manages PCO project budget needs (including FTEs, travel, education/professional development, etc.)
Tracks and manages status of PCO proposals, projects, and all other activities.
Pharmacovigilance System Master File Key Stakeholder (AE generating studies for ex-US Jazz marketed products)
Required/Preferred Knowledge, Skills, and Abilities
Required/Preferred Education and Licenses
Bachelor's Degree is essential, a Masters/PhD is preferred
#LI-DM1
Jazz Pharmaceuticals is an equal opportunity/affirmative action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any characteristic protected by law.
FOR US BASED CANDIDATES ONLY
Jazz Pharmaceuticals, Inc. is committed to fair and equitable compensation practices and we strive to provide employees with total compensation packages that are market competitive. For this role, the full and complete base pay range is: $172,000.00 - $258,000.00
Individual compensation paid within this range will depend on many factors, including qualifications, skills, relevant experience, job knowledge, and other pertinent factors. The goal is to ensure fair and competitive compensation aligned with the candidate's expertise and contributions, within the established pay framework and our Total Compensation philosophy. Internal equity considerations will also influence individual base pay decisions. This range will be reviewed on a regular basis.
At Jazz, your base pay is only one part of your total compensation package. The successful candidate may also be eligible for a discretionary annual cash bonus or incentive compensation (depending on the role), in accordance with the terms of the Company's Global Cash Bonus Plan or Incentive Compensation Plan, as well as discretionary equity grants in accordance with Jazz's Long Term Equity Incentive Plan.
The successful candidate will also be eligible to participate in various benefits offerings, including, but not limited to, medical, dental and vision insurance, 401k retirement savings plan, and flexible paid vacation. For more information on our Benefits offerings please click here: https://careers.jazzpharma.com/benefits.html.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing, and commercializing meaningful products that address unmet medical needs.
We have a diverse portfolio of products and product candidates, with a focus in the areas of sleep and hematology/oncology. We also support commercial products in other therapeutic areas where we can meaningfully address serious medical needs. As part of our unwavering commitment to improve patients’ lives, we are continuing to expand our commercial product portfolio and our research and development pipeline in therapeutic areas that can leverage our unique expertise. We do this through a growth strategy of growing sales of the existing medicines in our portfolio; acquiring commercial products or product candidates that are in late-stage development; and pursuing focused development of our pipeline of differentiated therapies.